Literature DB >> 6476892

Reduced response of scleroderma fibroblasts to fibroblast growth factor.

K Nishioka, Y Kobayashi, I Katayama, S Sano.   

Abstract

Reactivity of scleroderma fibroblasts to lymphoid cell-derived fibroblast growth factor (FGF) was assessed in this study. The fibroblasts from the sclerotic lesion failed to respond to FGF, whereas those from scleroedematous lesions responded equally to normal fibroblast. Response of the fibroblast from sclerotic lesion was also lower than that of the fibroblast from mature scar. Fibroblasts obtained from three different layers of healthy skin, papillary dermis, reticular dermis, and reticular-subcutaneous layer, responded equally to FGF, whereas the fibroblast of reticular dermis from sclerotic lesion failed to respond to FGF. It is suggested that the fibroblast of reticular dermis in scleroderma is variously activated by some unknown factors, so that they do not have enough reserve to respond to further stimuli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476892     DOI: 10.1007/bf00414232

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblasts.

Authors:  J S Perlish; R I Bashey; R E Stephens; R Fleischmajer
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

2.  Lymphokine stimulation of collagen accumulation.

Authors:  R L Johnson; M Ziff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 3.  The pathophysiology of scleroderma.

Authors:  R Fleischmajer
Journal:  Int J Dermatol       Date:  1977-06       Impact factor: 2.736

4.  Human skin fibroblasts derived from papillary and reticular dermis: differences in growth potential in vitro.

Authors:  R A Harper; G Grove
Journal:  Science       Date:  1979-05-04       Impact factor: 47.728

5.  Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.

Authors:  E C LeRoy; S Mercurio; G K Sherer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Mononuclear cell stimulation of fibroblast collagen synthesis.

Authors:  R L Spielvogel; J H Kersey; R W Goltz
Journal:  Clin Exp Dermatol       Date:  1978-03       Impact factor: 3.470

7.  Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

Authors:  J Uitto; E A Bauer; A Z Eisen
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 8.  Pathogenesis and staging of scleroderma.

Authors:  R K Winkelmann
Journal:  Acta Derm Venereol       Date:  1976       Impact factor: 4.437

9.  Fibroblast selection in scleroderma. An alternative model of fibrosis.

Authors:  G R Botstein; G K Sherer; E C Leroy
Journal:  Arthritis Rheum       Date:  1982-02

10.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  2 in total

1.  Response of scleroderma fibroblasts to various growth factors.

Authors:  K Takehara; Y Soma; A Igarashi; K Kikuchi; A Moro; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.

Authors:  Ufuk İlgen; Müçteba Enes Yayla; Nurşen Düzgün
Journal:  Clin Rheumatol       Date:  2016-11-22       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.